In the week of June 29, 2026, the RCM landscape reveals a strong investor appetite for innovative technologies aimed at enhancing patient care and streamlining operations. With substantial funding flowing into ophthalmology, AI-driven solutions, and chronic disease management, it's clear that capital is increasingly directed toward initiatives that promise to improve efficiency and compliance in healthcare delivery. This week's stories underscore a pivotal shift toward leveraging advanced technologies to tackle longstanding challenges in the industry.
STAT News
A startup focused on developing treatments for eye diseases has secured $330 million in funding to prepare for late-stage testing. This significant investment highlights growing investor interest in ophthalmology innovations. The influx of capital may accelerate advancements in the RCM market, particularly in the specialty of eye care.
Source →Fierce Healthcare
Coval has secured $28 million in a Series A funding round to enhance the reliability and compliance of its AI voice agent technology. The company intends to use the capital to bolster its sales and solutions engineering teams while advancing its product capabilities. This funding could significantly impact the RCM market by improving the deployment and operational efficiency of AI-driven solutions.
Source →STAT News
Digital health startup Cadence has secured $100 million in funding, reaching a valuation of $1.23 billion, to enhance its chronic disease management program using regulated AI technology. This investment underscores the growing focus on automating chronic disease care within the revenue cycle management (RCM) market. The key implication is that increased automation may lead to more efficient care delivery and improved patient outcomes in chronic disease management.
Source →Prior Authorization (Google News)
A House committee has advanced legislation aimed at reducing prior authorization requirements for radiology services, supported by the radiology community. The specific funding amount or financial details were not disclosed. This move could significantly streamline the approval process for radiology procedures, enhancing access to care and potentially impacting revenue cycles in the RCM market.
Source →Healthcare IT Funding & M&A (Google News)
Eolas Medical has raised £8.9 million in a Series A funding round led by Acton Capital. This investment aims to enhance Eolas Medical's capabilities in the revenue cycle management (RCM) sector. A key implication for the RCM market is the potential for increased innovation and competition as new technologies and solutions emerge from this funding.
Source →Fierce Healthcare
Assort Health has secured $120 million in a Series C funding round to enhance its voice AI agent platform tailored for the healthcare sector. The company boasts a substantial proprietary dataset, which includes 190 million patient interactions and extensive care protocols. This investment signals a growing interest in AI-driven solutions within revenue cycle management (RCM), potentially transforming patient engagement and operational efficiency in healthcare.
Source →Every deal, every week
Subscribe to the RevCycleAI newsletter. Free weekly RCM intelligence — deals, payer moves, and vendor deep dives.
Subscribe Free →